Clinical trials

  • CLARITHROMYCIN for Community-acquired pneumonia | Sepsis
  • LUFEPIRSEN for Persistent corneal epithelial defect
  • DOMVANALIMAB for Gastric adenocarcinoma | Gastroesophageal junction adenocarcinoma | Esophageal adenocarcinoma
  • NAVITOCLAX for Myelofibrosis|Myeloproliferative neoplasm
  • Cevostamab for Multiple myeloma | Relapsed or refractory multiple myeloma
  • SYN2 for Coronary artery disease
  • Adalimumab for Ulcerative colitis
  • METYRAPONE for Primary bilateral macronodular adrenal hyperplasia | Mild autonomous cortisol secretion (Mild Cushing syndrome)
  • FUTIBATINIB for Solid tumor | Esophageal cancer | Pancreatic ductal adenocarcinoma
  • MOLNUPIRAVIR for COVID-19 | SARS-CoV-2 infection
  • CARBOPLATIN for Triple-negative breast cancer | High-risk triple-negative breast cancer | Early-stage triple-negative breast cancer
  • LEVOBUPIVACAINE for Total hip arthroplasty